Skip to main content

COVID-19 Arthropathy and Myalgia

Sep 30, 2022 8:00 am

An online survey of random COVID-19 infected persons shows that arthralgia and myalgia are common consequences to COVID-19 infection.

Like other alphaviruses, the coronavirus has been reported to result in numerous musculoskeletal complaints. Researchers assessed the prevalence of viral arthropathy and myalgia associated with COVID-19, via a national, cross-sectional survey questionnaire administered online. Subjects with self-reported, but confirmed COVID-19 infection were recruited to fill out questionnaires.

While a total of 3222 participants completed questionnaire, only 1065 met inclusion criteria.  Of these,26.5% reported arthralgia and 53.2% reported myalgia at some point during or after COVID-19.  These symptoms persisted after the resolution of COVID, with 9.9% having arthralgia and 6.0% having myalgia, after resolution.

Predictors of COVID arthralgia included: hospitalization (OR 3.7), sore throat (OR 2.3), fatigue (OR 2.9) and ageusia/anosmia (OR 1.7). Similarly, there were predictors of myalgia including included arthralgia (OR 5.06), chest pain/discomfort (OR 1.49), headaches (OR 3.13), fever/chills (OR 2.24), and fatigue (OR 2.91).

While 68% reported having received a full course of SARS-CoV-2 vaccination, the temporal relationship between vaccination and myalgia or arthralgia was not studied. Yet those who were NOT vaccinated were more likely to report myalgia (57.6% versus 51.1%, p = 0.046) and arthralgia (30.1% versus 16.4%; p = 0.021).

Arthralgia and myalgia are common symptoms during and following COVID-19.



If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

The author has no conflicts of interest to disclose related to this subject